Trellus Management Company, LLC Ampio Pharmaceuticals, Inc. Transaction History

Trellus Management Company, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Jul 25, 2018	SELL	$1.66 - $3.82 $23,925 - $55,057	-14,413 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$2.16 - $3.48 $31,132 - $50,157	14,413 New	14,413 $49,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.